Effect of deramciclane, a new 5-HT receptor antagonist, on cholecystokinin-induced changes in rat gastrointestinal function

Author： Varga G. Kordas K. Burghardt B. Gacsalyi I. Szenasi G.

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.367, Iss.2, 1999-02, pp. : 315-323

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A 5-HT 3 receptor antagonist fails to prevent cisplatin-induced toxicity in immature rat spinal cord

By Whitaker-Azmitia P.M. Raio M. Raio D. Borella A.

European Journal of Pharmacology, Vol. 275, Iss. 2, 1995-03 ,pp. : 139-143

Elsevier

Access to resources Recommend Favorite

Antinociception in rat by sarpogrelate, a selective 5-HT 2A receptor antagonist, is peripheral

By Obata H. Saito S. Ishizaki K. Goto F.

European Journal of Pharmacology, Vol. 404, Iss. 1, 2000-09 ,pp. : 95-102

Elsevier

Access to resources Recommend Favorite

Effects of 5-HT 1A receptor antagonists on fluoxetine-induced changes in extracellular serotonin concentrations in rat frontal cortex

By Dawson L.A. Nguyen H.Q.

European Journal of Pharmacology, Vol. 345, Iss. 1, 1998-03 ,pp. : 41-46

Elsevier

Access to resources Recommend Favorite

M100907, a selective 5-HT 2A receptor antagonist, attenuates phencyclidine-induced Fos expression in discrete regions of rat brain

By Habara T. Hamamura T. Miki M. Ohashi K. Kuroda S.

European Journal of Pharmacology, Vol. 417, Iss. 3, 2001-04 ,pp. : 189-194

Elsevier

Access to resources Recommend Favorite

EMD 281014, a new selective serotonin 5-HT 2A receptor antagonist

By Bartoszyk G.D. van Amsterdam C. Bottcher H. Seyfried C.A.

European Journal of Pharmacology, Vol. 473, Iss. 2, 2003-07 ,pp. : 229-230

Elsevier

Access to resources Recommend Favorite